Trust Company of the Ozarks’s AbbVie ABBV Stock Holding History

Trust Company of the Ozarks’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.26M	Sell	23,082 -130	-0.6%	-$8.46K	0.43%	53
2015 Q2	$1.56M	Sell	23,212 -155	-0.7%	-$10.1K	0.43%	45
2015 Q1	$1.37M	Buy	23,367 +310	+1%	+$18.7K	0.36%	48
2014 Q4	$1.51M	Sell	23,057 -20	-0.1%	-$1.26K	0.42%	44
2014 Q3	$1.33M	Sell	23,077 -255	-1%	-$14.2K	0.38%	52
2014 Q2	$1.32M	Sell	23,332 -50	-0.2%	-$2.62K	0.36%	51
2014 Q1	$1.2M	Buy	23,382 +1,467	+7%	+$74.1K	0.34%	52
2013 Q4	$1.16M	Buy	21,915 +400	+2%	+$19.7K	0.33%	54
2013 Q3	$962K	Hold	21,515	–	–	0.3%	60
2013 Q2	$889K	Buy	+21,515	New	+$941K	0.3%	63

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Trust Company of the Ozarks's ABBV Position: Q3 2015 in Review

Trust Company of the Ozarks reduced its AbbVie (ABBV) stake by 0.56% in Q3 2015, selling an estimated $8.46K and leaving 23,082 shares worth $1.26M. The position accounts for 0.43% of the portfolio, ranked #53.

Trust Company of the Ozarks first reported a position in ABBV in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.56M in Q2 2015. 1,605 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

Trust Company of the Ozarks held 23,082 shares of AbbVie worth $1.26M as of Q3 2015.
Trust Company of the Ozarks sold 130 AbbVie shares in Q3 2015, an estimated $8.46K.
AbbVie made up 0.43% of Trust Company of the Ozarks's portfolio in Q3 2015, its #53 holding.
Trust Company of the Ozarks first reported a position in AbbVie in Q2 2013 and has held it in 10 quarters since.
Trust Company of the Ozarks's AbbVie position peaked at $1.56M in Q2 2015.
1,605 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on Trust Company of the Ozarks's 13F filing for Q3 2015, filed 4 Nov 2015.